1. Home
  2. IVA vs FMN Comparison

IVA vs FMN Comparison

Compare IVA & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • FMN
  • Stock Information
  • Founded
  • IVA 2011
  • FMN 2002
  • Country
  • IVA France
  • FMN United States
  • Employees
  • IVA N/A
  • FMN N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • FMN Investment Managers
  • Sector
  • IVA Health Care
  • FMN Finance
  • Exchange
  • IVA Nasdaq
  • FMN Nasdaq
  • Market Cap
  • IVA 117.3M
  • FMN 127.6M
  • IPO Year
  • IVA 2020
  • FMN N/A
  • Fundamental
  • Price
  • IVA $2.35
  • FMN $10.95
  • Analyst Decision
  • IVA Strong Buy
  • FMN
  • Analyst Count
  • IVA 4
  • FMN 0
  • Target Price
  • IVA $13.25
  • FMN N/A
  • AVG Volume (30 Days)
  • IVA 9.3K
  • FMN 22.8K
  • Earning Date
  • IVA 09-25-2024
  • FMN 01-01-0001
  • Dividend Yield
  • IVA N/A
  • FMN 3.86%
  • EPS Growth
  • IVA N/A
  • FMN N/A
  • EPS
  • IVA N/A
  • FMN N/A
  • Revenue
  • IVA $20,652,523.00
  • FMN N/A
  • Revenue This Year
  • IVA N/A
  • FMN N/A
  • Revenue Next Year
  • IVA $361.78
  • FMN N/A
  • P/E Ratio
  • IVA N/A
  • FMN N/A
  • Revenue Growth
  • IVA N/A
  • FMN N/A
  • 52 Week Low
  • IVA $1.53
  • FMN $9.09
  • 52 Week High
  • IVA $4.75
  • FMN $11.31
  • Technical
  • Relative Strength Index (RSI)
  • IVA 36.64
  • FMN 27.60
  • Support Level
  • IVA $2.22
  • FMN $11.45
  • Resistance Level
  • IVA $2.39
  • FMN $11.58
  • Average True Range (ATR)
  • IVA 0.10
  • FMN 0.10
  • MACD
  • IVA -0.03
  • FMN -0.04
  • Stochastic Oscillator
  • IVA 24.76
  • FMN 5.97

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About FMN Federated Hermes Premier Municipal Income Fund

Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers.. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.

Share on Social Networks: